TGX-25865-05564
3 vaccinations
4 coded responses
33 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 174 / PA
- Registered
- 2020-12-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-18
Dose 1 — Pfizer-BioNTech
-
2020-12-21
Registered in v-safe
- 2020-12-21
- 2020-12-22
- 2020-12-27
- 2021-01-01
-
2021-01-08
Dose 2 — Pfizer-BioNTech
- 2021-01-08
- 2021-01-09
-
2021-01-10
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tirednessFree text: Swollen lymph node on side of injection.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-17
- 2021-01-22
- 2021-01-29
- 2021-02-05
- 2021-02-12
- 2021-02-19
- 2021-04-09
- 2021-07-09
-
2021-12-15
Dose 3 — Pfizer-BioNTech
-
2021-12-16
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
-
2021-12-17
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · NauseaAdult check-in
- 2021-12-19
- 2021-12-20
- 2021-12-21
- 2021-12-24
- 2021-12-29
- 2022-01-05
- 2022-01-14
- 2022-01-21
- 2022-01-26
-
2022-03-16
Survey response — 3 months, dose 3MedDRA: Pre-eclampsia, Stillbirth — Feeling: Fair · Be unable to work or attend schoolFree text: Pre eclampsia and still birthMedDRA releases: 2024-11 · check-in free text available
-
2022-06-15
Survey response — 6 months, dose 3MedDRA: Hypertension — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: HTNMedDRA releases: 2024-11 · check-in free text available
-
2022-06-15
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-06-16
-
2022-12-17
Survey response — 12 months, dose 3MedDRA: Pregnancy — Feeling: GoodFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech | |
| 3 | 2021-12-15 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-06-15 | Unsuccessful |
Free text
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Swollen lymph node on side of injection.
Release 11 — 3 months, dose 3
Symptoms: Pre eclampsia and still birth
Release 12 — 6 months, dose 3
Symptoms: HTN
Release 12 — 12 months, dose 3
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Hypertension | · | · | ✓ |
| SD | Pre-eclampsia | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Stillbirth | · | · | ✓ |
| SRO | Injection site reaction | ○ | ○ | ○ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release